Clinical Trial Update: Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether PXS-4728A modulates microglia activation in individuals with isolated REM sleep behavior disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rem Sleep Behavior Disorder

Drugs mentioned

• PXS-4728A

Snippet

Sponsor: Syntara | Conditions: REM Sleep Behavior Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING